Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Salwa Albusaysi"'
Autor:
Mohammed S. Alasmari, Salwa Albusaysi, Marwa Elhefnawy, Ali M. Ali, Khalid Altigani, Mohammed Almoslem, Mohammed Alharbi, Jahad Alghamdi, Abdullah Alsultan
Publikováno v:
Saudi Pharmaceutical Journal, Vol 32, Iss 12, Pp 102207- (2024)
Model-Informed Drug Discovery and Development (MID3) represents a transformative approach in pharmaceutical research, integrating quantitative models to inform and optimize decision-making throughout the drug development process. This review explores
Externí odkaz:
https://doaj.org/article/f894e5b1296c4f638158a57ea223c718
Autor:
Sreedharan Sabarinath, Ramana S. Uppoor, Salwa Albusaysi, Bilal S AbuAsal, Mariam A. Ahmed, Priyank Patel, Mehul Mehta
Publikováno v:
Clinical Pharmacology & Therapeutics. 111:786-798
Several challenges are associated with rare disease drug development in neurology. In this article, we summarize the U.S. Food and Drug Administration's experience with clinical drug development for rare neurological diseases and discuss clinical pha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4c0bbef3ed3ea6d715a4ad27ef84720
https://doi.org/10.1002/cpt.2501
https://doi.org/10.1002/cpt.2501
Publikováno v:
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 38(6)
Depression has been associated with inflammation, and inflammation may both influence and interact with growth factors such as brain-derived neurotrophic factor (BDNF). Both the functional Val66Met BDNF polymorphism (rs6265) and BDNF levels have been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::101dd7fc672cf8f5703c26e8e863c44b
https://pubmed.ncbi.nlm.nih.gov/23303061
https://pubmed.ncbi.nlm.nih.gov/23303061